rs34144324
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001510.4(GRID2):c.203C>T(p.Thr68Met) variant causes a missense change. The variant allele was found at a frequency of 0.0424 in 1,612,220 control chromosomes in the GnomAD database, including 1,615 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. T68T) has been classified as Likely benign.
Frequency
Consequence
NM_001510.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRID2 | NM_001510.4 | c.203C>T | p.Thr68Met | missense_variant | 2/16 | ENST00000282020.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRID2 | ENST00000282020.9 | c.203C>T | p.Thr68Met | missense_variant | 2/16 | 1 | NM_001510.4 | P1 | |
GRID2 | ENST00000510992.5 | c.203C>T | p.Thr68Met | missense_variant | 2/15 | 1 | |||
GRID2 | ENST00000505687.5 | n.375C>T | non_coding_transcript_exon_variant | 2/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0359 AC: 5458AN: 152044Hom.: 116 Cov.: 32
GnomAD3 exomes AF: 0.0355 AC: 8907AN: 251148Hom.: 204 AF XY: 0.0365 AC XY: 4952AN XY: 135724
GnomAD4 exome AF: 0.0431 AC: 62857AN: 1460058Hom.: 1498 Cov.: 30 AF XY: 0.0424 AC XY: 30806AN XY: 726370
GnomAD4 genome AF: 0.0359 AC: 5461AN: 152162Hom.: 117 Cov.: 32 AF XY: 0.0348 AC XY: 2589AN XY: 74380
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2022 | See Variant Classification Assertion Criteria. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GRID2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at